Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (249)	5/23/2001 8:11:58 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 370

Dear Fellow Stockholder: You are cordially invited to attend the Company's Annual Meeting of stockholders to be held at 10:00 a.m., on Thursday, July 26, 2001 at the Kitano Hotel, 66 Park Avenue, New York, New York 10016. This year you are being asked to: (i) elect seven directors; (ii) approve an amendment to the Company's Certificate of Incorporation to increase the Company's authorized shares of common stock from 35,000,000 shares to 100,000,000 shares; (iii) approve an increase in the number of authorized shares that may be granted under the Amended and Restated 1993 Stock Option Plan; and (iv) ratify the appointment of Ernst & Young LLP as the Company's independent auditors for 2001. At the meeting, I will be pleased to report on the affairs of the Company and a discussion period will be provided for questions and comments of general interest to stockholders. Number of shares Percent of outstanding Directors, Officers & 5% Stockholders beneficially owned shares of Common Stock ------------------------------------- ------------------ ---------------------- Michel C. Bergerac........................................ 28,250(1) * Stephen K. Carter ........................................ 0 * Frank T. Cary............................................. 80,968(2) * Alan Kessman.............................................. 436,500(3) 1.7% William R. Miller......................................... 199,406(4) * Alan C. Sartorelli, Ph.D.................................. 418,455(5) 1.6% Walter B. Wriston......................................... 75,968(6) * Charles MacDonald......................................... 10,000(7) * Mario Sznol, M.D.......................................... 50,000(8) * Terrence W. Doyle, Ph.D................................... 280,224(9) 1.1% Bijan Almassian, Ph.D..................................... 66,625(10) * Ivan King, Ph.D........................................... 86,400(11) * Thomas Mizelle............................................ 162,960(12) * Thomas E. Klein........................................... 40,102(13) * All directors and executive officers as a group (12 persons) ........................................... 1,732,796(14) 6.6% Other Beneficial Owners ----------------------- Elliott Associates, L.P. Elliott International, L.P. (f/k/a Westgate International, L.P.) Martley International, Inc. c/o Elliott Associates, L.P. 712 Fifth Avenue, 36th Floor New York, NY 10019..................................... 2,966,113(15) 11.3%